We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Failure to assure that an IRB complying with applicable regulatory requirements was responsible for the initial and continuing review and approval of a clinical study.